Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael M Hopkins

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 1, 2007
Is primary care the right place for genetic diagnosis?Michael M Hopkins
Nature Biotechnology|June 9, 2012
Biomarker patents for diagnostics: problem or solution?Michael M Hopkins, Stuart Hogarth
Expert Review of Neurotherapeutics|December 22, 2006
Role of pharmacogenetics in the use of CNS drugs: from drug pipeline to primary care?Michael M Hopkins, Paul A Martin
Sociology of Health & Illness|November 29, 2011
A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USAStuart Hogarth, Michael M Hopkins, Victor Rodriguez
Future Healthcare Journal|July 21, 2021
Supporting the vital role of boundary-spanning physician researchers in the advancement of medical innovationMichael M Hopkins, Fabien Ibanez, Malcolm Skingle
Nature Biotechnology|November 28, 2002
Shares in the human genome--the future of patenting DNASandy M Thomas, Michael M Hopkins, Max Brady
Nature Biotechnology|February 9, 2007
DNA patenting: the end of an era?Michael M Hopkins, Surya Mahdi, Pari Patel, et al.
Drug Discovery Today|January 4, 2025
Academic Drug Discovery Units in the UK: Progress and challengesMichael M Hopkins, Jorge Mestre-Ferrandiz, Phillipa Crane, et al.
Nature|March 28, 2009
The phantom menace of gene patentsSibylle Gaisser, Michael M Hopkins, Kathleen Liddell, et al.
BMJ (Clinical Research Ed.)|November 11, 2025
Policies to promote affordability and access across the life cycle of costly new drugsKrista Kruja, Jorge Mestre-Ferrandiz, Michael M Hopkins, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
The British Journal of General Practice : the Journal of the Royal College of General Practitioners|September 1, 2007
Is primary care the right place for genetic diagnosis?Michael M Hopkins
Nature Biotechnology|June 9, 2012
Biomarker patents for diagnostics: problem or solution?Michael M Hopkins, Stuart Hogarth
Expert Review of Neurotherapeutics|December 22, 2006
Role of pharmacogenetics in the use of CNS drugs: from drug pipeline to primary care?Michael M Hopkins, Paul A Martin
Sociology of Health & Illness|November 29, 2011
A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USAStuart Hogarth, Michael M Hopkins, Victor Rodriguez
Future Healthcare Journal|July 21, 2021
Supporting the vital role of boundary-spanning physician researchers in the advancement of medical innovationMichael M Hopkins, Fabien Ibanez, Malcolm Skingle
Nature Biotechnology|November 28, 2002
Shares in the human genome--the future of patenting DNASandy M Thomas, Michael M Hopkins, Max Brady
Nature Biotechnology|February 9, 2007
DNA patenting: the end of an era?Michael M Hopkins, Surya Mahdi, Pari Patel, et al.
Drug Discovery Today|January 4, 2025
Academic Drug Discovery Units in the UK: Progress and challengesMichael M Hopkins, Jorge Mestre-Ferrandiz, Phillipa Crane, et al.
Nature|March 28, 2009
The phantom menace of gene patentsSibylle Gaisser, Michael M Hopkins, Kathleen Liddell, et al.
BMJ (Clinical Research Ed.)|November 11, 2025
Policies to promote affordability and access across the life cycle of costly new drugsKrista Kruja, Jorge Mestre-Ferrandiz, Michael M Hopkins, et al.
Pageof 2